Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 15 min ago

Oncology

5,176 studies502 in 7 days2,477 in 30 days

Filters
Type
Date
Clear

Latest

5,176 studies

  1. Proton treatment-plan dose verification with a DPM-based Monte Carlo engine
    Aimee L. McNamara, Daniel O’Brien, Alan Nelson
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  2. Frailty and associated factors in patients with non-Hodgkin lymphoma during chemotherapy: a longitudinal study
    Ying Zhang, Ruofei Du, Yating Du +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  3. Prospective comparison of CT- and MRI-based tumor delineation based on intraoperative navigation and spatially annotated pathology in locally advanced midfacial squamous cell carcinoma
    Lukas Bauer, Reinald Kühle, Jennifer Fuchs +14
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  4. Targeting autocrine CCL2 signaling reveals oncogenic networks and prognostic biomarkers in medulloblastoma
    Howard Donninger, Elizabeth B. Amona, Raphael Jigo +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  5. Case Report: Durable response to tislelizumab monotherapy in microsatellite-stable, BRAF V600E-mutant right-sided colon cancer with extremely high PD-L1 expression
    Chen Li, Mingyan Li, Simin Wang +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  6. Case Report: Concurrent breast myeloid sarcoma and ductal carcinoma in situ—multimodality imaging findings and differential treatment response
    Chungpill Kang, Hye Young Choi, Ho Cheol Choi +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  7. piR-131582 suppresses lung adenocarcinoma progression by targeting USP22 and inhibiting EMT
    Shunjin Zhao, Tianfu Zeng, Ning Liu +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  8. Influence of the initial recurrence and metastatic site on outcomes in postoperative gastric cancer patients
    Zhanghui Li, Mengxiao Lu, Minming Xia +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyFrontiersCrossrefDOAJ
  9. Persistence of pulmonary infiltrates despite effective anti-infective therapy as a diagnostic clue for pembrolizumab-induced pneumonitis: a case report
    Li Zhao, Yeming Wang
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  10. Case Report: Multimodal treatment of cervical intramedullary spinal cord metastasis from gastric adenocarcinoma
    Yingna Wu, Yu Dai, Tao Fan +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  11. Anlotinib combined with chemotherapy in metastatic desmoplastic small round cell tumor: a case report
    Yalu Dong, Weiwei He, Qian Xie +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  12. Expression of phospho-S6 and its correlation with clinicopathological characteristics in retroperitoneal extravisceral perivascular epithelioid cell tumors
    Lei Liu, Wenjie Li, Shibo Liu +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  13. An integrated serum peptidomics and multi-algorithm machine learning approach for early diagnosis of lung cancer
    Li Cao, Jie Ding, Aihong Guo +9
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  14. Nutrient Availability as a Driver of Transcriptome Reprogramming in Osteosarcoma
    J. M. Tomczak, Z. Senkowska, E. Weglarz-Tomczak
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  15. Multi-omics and Functional Analyses Identify Cancer-associated Fibroblast-derived Insulin-like Growth Factor 1 as a Stromal Mediator of Lung Adenocarcinoma Progression.
    Jingwen Deng, Jin Sheng, Liangkun You +7
    MedCommPeer-reviewedCC BYFull textOncologyEurope PMC
  16. Type 1 Diabetes and Breast Cancer Risk: Evidence From an Updated Meta-Analysis and Mendelian Randomization Study.
    Yi Xie, Qimou Lin, Jianhua Guan +4
    International journal of endocrinologyPeer-reviewedCC BYFull textOncologyEurope PMC
  17. ABCB4 Deficiency Presenting as a Pruritus-Free Continuous Spectrum From Childhood Cholestasis to Adult Cirrhosis: A Case Report.
    Rongxia Ma, Wenjie Zhang, Xiaojuan Yang +1
    Clinical case reportsPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  18. State of Precision Oncology: An Australian Perspective.
    Samrin Liaqat, Muhammad Adnan Khattak
    Journal of immunotherapy and precision oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  19. Molecular Profiling in Asia: The Current Status and Approach.
    Sewanti Limaye, Herbert Loong, Mahin Bhatt +1
    Journal of immunotherapy and precision oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  20. Combined casein kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancer
    Mattia Marinucci, Federico Donà, Gina F. Boot +19
    Experimental Hematology & OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  21. FSP1 as the convergent hub of autophagy and ubiquitination governing ferroptosis in monocrotaline‐induced pulmonary arterial hypertension
    Dandan Chen, Qi Jin, Lei Zhang +4
    Clinical and Translational MedicinePeer-reviewedCC BY 4.0Full textOncologyPMC
  22. Impact of Tissue Storage on Bioanalytical Data and Live Tissue Science
    Erick Beltran, Ben Youngs, Luke Allen +17
    Current Oncology ReportsPeer-reviewedCC BY 4.0Full textOncologyPMC
  23. Bioengineering strategies for off-the-shelf, cell-based cancer immunotherapy
    Brendan R. Barlow, Ana M. Sandoval-Castellanos, Robert J. Canter +1
    Med-XPeer-reviewedCC BY 4.0Full textOncologyPMC
  24. CBTRUS Statistical Facts
    Neuro-OncologyPeer-reviewedPublisher termsFull textOncologyPMC
  25. Cancer Survivors' Experiences With Six Months of Community Health Worker Health‐Related Social Needs Support: A Qualitative Analysis of Perceived Impact
    Arianna Milicia, Marjanna Smith, Jessica Rivera Rivera +3
    Psycho-OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC